Delivery Order SPE2DB24D1205-SPE2DB25FCVHN

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $39,156.42 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 7, 2025. The contract provides for the delivery of 4566847882 units of LATUDA 40 MG TABLET 30S, a pharmaceutical product. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,287.41, is a delivery order to provide LATUDA 40 MG TABLET 30S to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,938.24 firm fixed-price delivery order is for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through March 31, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,629.42, is for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through July 18, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award, valued at $9,571.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LATUDA 40 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award has been issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,223.77, is a delivery order for the supply of LATUDA 40 MG TABLET 30S, a medication used for the treatment of mental health conditions. The award has an ultimate completion date of November 14, 2024 and is a firm fixed-price contract. There is no set-aside designation, indicating this was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $3,200.64, is for the delivery of LATUDA 40 MG TABLET 30S, a prescription medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of LATUDA 40 MG TABLET 30S, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $11,334.75 and an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp is the prime contractor for this award, which is not set aside. The company is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.97 firm fixed-price delivery order is for the supply of Latuda 40 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $9,044.74 firm fixed-price delivery order is for 4568267352 - LATUDA 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 19, 2025 and was awarded on May 16, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVHN
    Delivery Order

This federal contract award, valued at $11,245.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of March 28, 2025.

The contract is for the supply of LATUDA 40 MG TABLET 30S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned. The DLA, a defense agency, is the funding agency for this contract, which aligns with the company's significant focus on supporting military and veterans' healthcare systems through federal contracts.

Generated 6/26/25, 10:07 AM